Cost Plus Drugs CEO Alex Oshmyansky TK on the latest episode of the “Rapid Response” podcast.

Some of the world's largest hedge funds are hiring doctors, scientists and analysts to give them expert insight into the ...

Some of the world's largest hedge funds are hiring doctors, scientists and analysts to give them expert insight into the ...

Artificial intelligence is changing the way industries do business. But executives in the pharmaceutical industry are still ...

At a time when geopolitical tensions are hitting industries from semiconductors to electric vehicles, pharmaceutical ...

While antiviral drugs to treat HIV had been approved a decade earlier, only five out of 33 million people who carried the ...

The U.S. pharmaceutical industry is pushing to revamp the new law that allows Medicare to negotiate prices for its costliest ...

Mark Cuban (entrepreneur, investor, and founder, Cost Plus Drugs) joins Chris Cuomo to discuss disrupting Big Pharma, ...

Pharma companies lobby for changes to Medicare drug price rules, targeting a four-year delay for pills' eligibility. Critics ...

After three years of mounting pressure from AIDS activists, the pharma companies finally dropped their case. While this story has a happy ending, Mandela’s battle against Big Pharma was only a ...

Recent health news highlights include Novavax's $200 million sale of its Czech unit, UnitedHealth's higher medical cost ...